Drug Shortage Report for PAMIDRONATE DISODIUM OMEGA 9 MG/ML
Report ID | 215446 |
Drug Identification Number | 02249685 |
Brand name | PAMIDRONATE DISODIUM OMEGA 9 MG/ML |
Common or Proper name | Pamidronate Disodium For Injection |
Company Name | OMEGA LABORATORIES LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | PAMIDRONATE DISODIUM |
Strength(s) | 9.0MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 1 x 10mL vial /fiole |
ATC code | M05BA |
ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-01-16 |
Estimated end date | 2024-02-16 |
Actual end date | 2024-02-12 |
Shortage status | Resolved |
Updated date | 2024-02-13 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 11177 HAMON MONTREAL, QUEBEC CANADA H3M 3E4 |
Company contact information | info@omegalaboratory.com - 1-800-363-0584 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2024-02-13 | English | Compare |
v7 | 2024-02-09 | French | Compare |
v6 | 2024-02-09 | English | Compare |
v5 | 2024-01-17 | English | Compare |
v4 | 2024-01-15 | French | Compare |
v3 | 2024-01-15 | English | Compare |
v2 | 2024-01-09 | French | Compare |
v1 | 2024-01-09 | English | Compare |
Showing 1 to 8 of 8